8108
D. Thongkum, T. Tuntulani / Tetrahedron 67 (2011) 8102e8109
molecular sieve and Raney Ni were removed by filtration. The
residue was evaporated to dryness and extracted with CH2Cl2 and
H2O. The organic phase was collected and dried over anhydrous
Na2SO4. Solvent was evaporated to give a yellow oil product in
a quantitative yield. The product was used in the next step
without further purification.
125.1, 124.9, 124.4, 123.8, 122.7, 116.8, 113.0, 109.7, 69.9, 68.9, 68.0,
55.4 ppm.
4.2.8. Compound L3. A similar procedure to the preparation of L1,
L3 was synthesized from the coupling reaction of compound 8 and
compound 9. The compound L3 was obtained as yellow powders
(0.045 g, 52%). MALDI-TOF (m/z) [M]þ: calcd 866.26, found 865.07.
Elemental analysis for C52H42N4O5S2: calcd C, 72.03; H, 4.88; N,
4.2.4. Compound 11. A mixture of 10 (3.48 g, 0.025 mol), anhy-
drous K2CO3 (1.73 g, 0.0125 mol) in CH3CN (25 mL) was refluxed
under nitrogen. CH3I (3 mL, 0.0482 mol) in CH3CN (25 mL) was
added dropwise to the mixture. After 5 h, the solvent was re-
moved under reduced pressure. The residue was dissolved in
CH2Cl2 and 3 M HCl was added until the pH of the solution be-
came 1. The solvent was removed, and the resulting residue was
extracted with CH2Cl2 (25 mLꢁ3) and water. The organic phase
was dried over anhydrous Na2SO4, filtered, and the solvent was
removed. The crude residue was purified by column chromato-
graph using CH2Cl2 as eluent to yield compound 11 as a yellowish
green solid (3.65 g, 95%). MALDI-TOF (m/z) [M]þ: calcd 153.04,
found 153.99. IR (KBr): 1500 (nasym. NO2), 1333 (nsym. NO2) cmꢀ1. 1H
6.46. Found C, 72.25; H, 4.86; N, 6.42. IR (KBr): 1509 (
NMR (400 MHz, DMSO-d6) 10.02 (s, 2H), 9.69 (s, 2H), 8.28e8.02
(m, 18H), 7.16 (d, J¼2 Hz, 2H), 6.92 (m, 4H), 4.03 (t, J¼4 Hz, 4H), 3.71
(m, 10H) ppm. 13C NMR (100 MHz, DMSO-d6)
181.0, 148.4, 145.1,
n
C]S) cmꢀ1. 1H
d
d
133.0, 132.5, 130.4, 130.2, 129.0, 127.2, 127.0, 126.8, 126.5, 126.3,
126.2, 125.1, 124.9, 124.7, 124.2, 123.6, 122.5, 116.6, 113.0, 109.5, 68.8,
67.9, 55.2 ppm.
4.2.9. Compound L4. Compound 12 (0.300 mmol) and triethyl-
amine (0.20 mL, 1.5 mmol) in CHCl3 (10 mL) was stirred under ni-
trogen at room temperature for 30 min and then compound 9
(0.093 g, 0.360 mmol) in CHCl3 (20 mL) was added to the reaction.
The reaction mixture was stirred for 3 days, and the solvent was
evaporated to dryness. The residue was extracted with CH2Cl2 and
H2O. The organic phase was collected, evaporated to dryness, and
purified by recrystallization with CH2Cl2/EtOAc to give a white solid
of L4 (0.037 g, 32%). MALDI-TOF (m/z) [M]þ: calcd 382.11, found
382.70. Elemental analysis: for C24H18N2OS: calcd C, 75.37; H, 4.74;
NMR (400 MHz, CDCl3)
d
8.19 (dd, J¼7.2, 2.0 Hz, 2H), 6.95 (dd,
J¼7.2, 2.0 Hz, 2H), 3.9 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3)
d
164.6, 141.6, 125.9, 114.0, 56.0 ppm.
4.2.5. Compound 12. A mixture of 11 (0.05 g, 0.3 mmol) in CH3OH
(1 mL) and EtOAc (20 mL) was stirred with molecular sieve under
nitrogen. After 15 min, Raney Ni (1/4 spoon) and 2 mL of hydra-
zine hydrate were added and refluxed for 1 h. The color of the
reaction was changed from yellow to colorless. The molecular
sieve and Raney Ni were removed by filtration. The residue was
evaporated to dryness and extracted with CH2Cl2 and H2O. The
organic phase was collected and dried over anhydrous Na2SO4.
Solvent was evaporated to give a yellow oil. The product was used
in the next step without purification.
N, 7.32. Found C, 75.40; H, 4.83; N, 7.41. IR (KBr): 1512 (n .
C]S) cmꢀ1
1H NMR (400 MHz, CDCl3)
d
8.05 (m, 11H), 7.32 (d, J¼8 Hz, 2H), 6.90
(d, J¼8 Hz, 2H), 3.79 (s, 3H) ppm. 13C NMR (100 MHz, DMSO-d6)
181.6, 156.6, 133.0, 132.2, 130.6, 130.4, 129.2, 127.3, 127.1, 126.9,
126.6, 126.4, 126.3, 125.3, 125.1, 124.8, 124.4, 123.8, 122.6, 113.5,
55.1 ppm.
4.3. Spectrofluorometry
4.3.1. Anion titrations. Solutions of compounds L1eL3 (5.0ꢁ10ꢀ6 M)
and L4 (5.0ꢁ10ꢀ5 M) were prepared in a 10 mL volumetric flask and
2 mL of each ligand was pipetted into a 1 cm path length quartz
cuvette. The emission spectra were recorded in the range
360e650 nm at room temperature by using the excitation wave-
length at 340 nm. The solution of an anion (1.0ꢁ10ꢀ3 or 1.0ꢁ10ꢀ2 M
up to concentration of ligand) was prepared in a 10 mL volumetric
flask and transferred to a 2 mL microburette. The anion solution was
introduced in portions to the cuvette and stirred for 60 s prior to
measurement.
4.2.6. Compound L1. A solution of compound 6 (0.100 mmol) and
triethylamine (0.10 mL, 0.717 mmol) in CHCl3 (10 mL) was stirred
under nitrogen at room temperature for 30 min and then com-
pound 9 (0.066 g, 0.255 mmol) in CHCl3 (20 mL) was added to the
reaction. The reaction mixture was stirred for 3 days and then
evaporated to dryness. The residue was extracted with CH2Cl2 and
H2O. The organic phase was collected and evaporated to dryness
and purified by column chromatography using EtOAc as eluent.
The final product L1 was recrystallized with CH2Cl2/CH3OH to give
a yellow solid (0.046 g, 48%). Mp: 140.0e142.8 ꢂC. MALDI-TOF (m/
z) [Mþ]: calcd 954.31, found 953.0. Elemental analysis for
C56H50N4O7S2: calcd C, 70.42; H, 5.28; N, 5.87. Found C, 70.40; H,
4.3.2. Metal ion titrations. The preparations of the ligands were
similar to the titration of anions. However, the sodium solution
(1.0ꢁ10ꢀ3 M or 1.0ꢁ10ꢀ2 M) was prepared in CH3CN and was in-
troduced in portions to the cuvette by a microburette. The mixture
between the ligand and sodium was stirred for 2 min prior to
measurement.
5.23; N, 5.82. IR (KBr): 1513 (n .
C]S) cmꢀ1 1H NMR (400 MHz,
CDCl3)
d 8.0 (m, 22H), 7.0 (s, 2H), 6.8 (s, 4H), 4.1 (s, 4H), 3.8 (s,
10H), 3.6 (d, J¼7.6 Hz, 8H) ppm. 13C NMR (100 MHz, DMSO-d6)
d
181.2, 148.5, 145.3, 133.2, 132.6, 130.6, 130.4, 129.2, 127.3, 127.1,
127.0, 126.7, 126.4, 126.3, 125.3, 125.1, 124.8, 124.4, 123.8, 122.7,
116.7, 113.0, 109.7, 69.8, 69.7, 68.9, 68.0, 55.4 ppm.
4.4. 1H NMR spectroscopy
4.4.1. Anion titrations. The solution of a ligand (1.0ꢁ10ꢀ3 M) in
CDCl3 (0.5 mL) was prepared in a 5 mm of an NMR tube. The 1H
NMR spectrum of the free ligand was recorded. The solution of
fluoride ion (1.0ꢁ10ꢀ2 M) in CDCl3 (1.0 mL) was prepared in a vial.
Then, fluoride solution was added in portions to the NMR tube via
4.2.7. Compound L2. A similar procedure to the preparation of L1,
L2 was synthesized from the coupling reaction of compound 7 and
compound 9. The compound L2 was obtained as yellow powders
(0.035 g, 38%). MALDI-TOF (m/z) [M]þ: calcd 910.290, found
909.407. Elemental analysis for C54H46N4O6S2: calcd C, 71.19; H,
5.09; N, 6.15. Found C, 71.05; H, 4.92; N, 6.20. IR (KBr): 1509
a microsyringe (10 and 50
mixture was recorded.
m
L portions). 1H NMR spectrum of the
(n d 10.07 (s, 2H), 9.73 (s,
C]S) cmꢀ1. 1H NMR (400 MHz, DMSO-d6)
2H), 8.31e8.06 (m, 18H), 7.20 (d, J¼2 Hz, 2H), 6.97 (dd, J¼27,
4.4.2. Metal ion titrations. The solution of ligand L1 (1.0ꢁ10ꢀ3 M) in
CDCl3/CD3CN (9/1 v/v) (0.5 mL) was prepared in a 5 mm NMR tube.
The 1H NMR spectrum of free ligand was recorded. The solution of
8.8 Hz, 4H), 4.04 (t, J¼4.8 Hz, 4H), 3.74 (m, 10H), 3.60 (s, 4H) ppm.
13C NMR (100 MHz, DMSO-d6)
d 181.2, 148.5, 145.3, 133.2, 132.6,
130.6, 130.4, 129.2, 127.3, 127.2, 127.0, 126.7, 126.4, 126.4, 125.3,